Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Deguelin
Cat. No.:
OB0225LY-0275
Appearance:
Solid
Purity:
≥98%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Add to basket
Product Overview
Description:
Deguelin is a compound derived from Mundulea sericea that exhibits antitumor and anti-inflammatory properties.
Synonym:
(-)-Deguelin; (-)-cis-Deguelin; 522-17-8; (7aS,13aS)-9,10-Dimethoxy-3,3-dimethyl-13,13a-dihydro-3H-pyrano[2,3-c:6,5-f']dichromen-7(7aH)-one; (1S,14S)-17,18-Dimethoxy-7,7-dimethyl-2,8,21-trioxapentacyclo[12.8.0.03,12.04,9.015,20]docosa-3(12),4(9),5,10,15,17,19-heptaen-13-one; (7aS,13aS)-9,10-dimethoxy-3,3-dimethyl-13,13a-dihydro-3H-pyrano[2,3-c:6,5-f']dichromen-7(7aH)-one
CAS No.:
522-17-8
Compound CID:
107935
Formula:
C23H22O6
Formula Weight:
394.42
Specification
Source:
Mundulea sericea
Relative Density:
1.255 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Deguelin can be used for studies on the effects of cell proliferation and apoptosis.
Library Information
Targets:
PI3K family; HSP family; NF-κB family
Receptors:
Akt; PI3K
Pathways:
Apoptosis; Autophagy; Cytoskeletal signaling; PI3K/Akt/mTOR signaling
Plate Number:
AOCL-4
Plate Location:
e4
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
50 mg/mL; 126.77 mM
Ethanol Max Solubility:
19.7 mg/mL; 50 mM
ALogP:
3.567
HBA_Count:
6
HBD_Count:
0
Rotatable Bond:
2
